Oral pharmaceutical composition of a poorly water-soluble active substance

Details for Australian Patent Application No. 2007259252 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Gorissen, Henricus R.M.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007259252

PCT Pub. Number WO2007/144418

Priority 06115582.6 16.06.06 EP; 60/814,076 16.06.06 US

Filing date 15 June 2007

Wipo publication date 21 December 2007

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 45/08 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

12 February 2009 PCT application entered the National Phase

  PCT publication WO2007/144418 Priority application(s): WO2007/144418

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007259255-Combination preparations comprising SLV308 and a L-DOPA

2007259232-Hydrolysed egg proteins